Page last updated: 2024-09-04

naproxen and Acute Confusional Senile Dementia

naproxen has been researched along with Acute Confusional Senile Dementia in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	21 (50.00)	29.6817
2010's	17 (40.48)	24.3611
2020's	4 (9.52)	2.80

Authors

Authors	Studies
Bain, G; Beher, D; Chen, W; Jiang, X; Munoz, B; Peachey, J; Prasit, P; Shearman, MS; St-Jacques, R; Stock, N; Williamson, TL; Wrigley, JD	1
Cui, MC; Duan, XH; Liu, BL; Qiao, JP; Yang, Y; Zhou, JN	1
A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X	1
Ashford, JW	1
Breitner, J; Meyer, PF	1
Devane, D; Jordan, F; Kelly, JP; McGuinness, B; Murphy, K; Passmore, P; Quinn, TJ; Tudur Smith, C	1
Hershey, LA; Lipton, RB	1
Breitner, J; Etienne, P; Lafaille-Magnan, ME; Leoutsakos, J; Madjar, C; Meyer, PF; Poirier, J; Rosa-Neto, P; Savard, M; Tremblay-Mercier, J	1
Karceski, S	1
Breitner, JCS; Labonté, A; Meyer, PF; Poirier, J; Rosa-Neto, P	1
Brandt, J; Breitner, JC; Luis, CA; Martin, B; Reckess, GZ; Zandi, P	1
Bartlett, AL; Forrester, SN; Leoutsakos, JM; Lyketsos, CG	1
Dutta, G; Ghosh, T; Goswami, AR; Sil, S	1
Cacciatore, I; Cerasa, LS; Costantini, E; D'Angelo, C; Di Stefano, A; Eusepi, P; Fornasari, E; Marinelli, L; Pomilio, C; Reale, M; Türkez, H	1
Breitner, JC; McCaffrey, LD; Meinert, CL	1
Bregman, N; Karni, A; Korczyn, AD	1
Bhaskar, K; Herrup, K; Kounnas, MZ; Lamb, BT; Varvel, NH; Wagner, SL; Yang, Y	1
Baker, LD; Breitner, JC; Milne, G; Montine, TJ; Sonnen, JA	1
Chang, WE; Kim, S; Klimov, DK; Kumar, R	1
Breitner, JC; Leoutsakos, JM; Lyketsos, CG; Muthen, BO	1
Barrio, JR; Chen, PP; Cole, GB; Cole, GM; Flood, DG; Frautschy, SA; Huang, SC; Jones, MR; Kepe, V; Liu, J; Satyamurthy, N; Small, GW; Teng, E; Trusko, SP; Yang, F	1
Ashe, KH; Baker, LD; Brandt, J; Breitner, JC; Craft, S; Evans, DE; Green, RC; Ismail, MS; Lyketsos, CG; Martin, BK; Meinert, CL; Montine, TJ; Mullan, MJ; Sabbagh, M; Tariot, PN	1
Klimov, DK; Lockhart, C	1
Helmuth, L	1
Agdeppa, ED; Barrio, JR; Cole, GM; Huang, SC; Kepe, V; Liu, J; Petri, A; Satyamurthy, N; Small, GW	1
Aisen, PS; Grundman, M; Schafer, K; Thal, LJ; Thomas, R	1
Aisen, PS; Davis, KL; Farlow, MR; Grundman, M; Jin, S; Pfeiffer, E; Sano, M; Schafer, KA; Thal, LJ; Thomas, RG	1
Breitner, JC	1
Czap, A	1
Robertson, M	1
Gertz, BJ; Reicin, A; Sperling, RS; Weir, MR	1
Ambegaokar, SS; Begum, AN; Chen, PP; Cole, GM; Frautschy, SA; Glabe, CG; Kayed, R; Lim, GP; Simmons, MR; Ubeda, OJ; Yang, F	1
LeVine, H	1
Gregor, P; Ormiston, TM; Raina, P; Salpeter, SR; Thabane, L; Topol, EJ; Whitlock, R	1
Breitner, JC; Green, RC; Lyketsos, CG; Martin, BK; Meinert, C; Piantadosi, S; Sabbagh, M	1
Brandt, J; Breitner, JC; Craft, S; Evans, D; Green, R; Martin, BK; Mullan, M; Piantadosi, S; Szekely, C	1
Asanuma, M; Kohno, M; Miyazaki, I; Nishibayashi-Asanuma, S; Ogawa, N	1
Barr, E; Gertz, BJ; Konstam, MA; Reicin, A; Shapiro, D; Sperling, RS; Weir, MR	1
Press, D	1

Reviews

6 review(s) available for naproxen and Acute Confusional Senile Dementia

Article	Year
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease. Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12 Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult	2022
Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia. The Cochrane database of systematic reviews, 2020, 04-30, Volume: 4 Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Cyclooxygenase 2 Inhibitors; Dementia; Hemorrhage; Humans; Incidence; Lactones; Middle Aged; Myocardial Infarction; Naproxen; Randomized Controlled Trials as Topic; Stroke; Sulfones	2020
NSAIDs and Alzheimer's disease: how far to generalise from trials? The Lancet. Neurology, 2003, Volume: 2, Issue:9 Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Humans; Naproxen; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides	2003
Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program. American heart journal, 2003, Volume: 146, Issue:4 Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Blood Pressure; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Interactions; Drug Therapy, Combination; Endothelium, Vascular; Epoprostenol; Humans; Isoenzymes; Lactones; Membrane Proteins; Models, Animal; Naproxen; Osteoarthritis; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Randomized Controlled Trials as Topic; Sulfones; Thrombosis; Thromboxanes	2003
Meta-analysis: cardiovascular events associated with nonsteroidal anti-inflammatory drugs. The American journal of medicine, 2006, Volume: 119, Issue:7 Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Humans; Joint Diseases; Naproxen; Randomized Controlled Trials as Topic; Risk Factors	2006
Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib. Circulation, 2001, Nov-06, Volume: 104, Issue:19 Topics: Aged; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cardiovascular Diseases; Chronic Disease; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Clinical Trials, Phase IV as Topic; Comorbidity; Cyclooxygenase 1; Cyclooxygenase 2; Female; Humans; Isoenzymes; Lactones; Low Back Pain; Male; Membrane Proteins; Middle Aged; Naproxen; Osteoarthritis; Proportional Hazards Models; Prostaglandin-Endoperoxide Synthases; Randomized Controlled Trials as Topic; Risk; Sulfones; Thrombosis	2001

Trials

14 trial(s) available for naproxen and Acute Confusional Senile Dementia

Article	Year
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease. Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12 Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult	2022
INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease. Neurology, 2019, 04-30, Volume: 92, Issue:18 Topics: Aged; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Double-Blind Method; Female; Humans; Male; Middle Aged; Naproxen; Prodromal Symptoms; Treatment Outcome	2019
No apparent effect of naproxen on CSF markers of innate immune activation. Annals of clinical and translational neurology, 2019, Volume: 6, Issue:6 Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Celecoxib; Cytokines; Female; Humans; Interferon alpha-2; Interleukin 1 Receptor Antagonist Protein; Male; Middle Aged; Naproxen	2019
Results of a follow-up study to the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT). Alzheimer's & dementia : the journal of the Alzheimer's Association, 2013, Volume: 9, Issue:6 Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents; Celecoxib; Cognition Disorders; Double-Blind Method; Female; Humans; Inflammation; Longitudinal Studies; Male; Naproxen; Physical Examination; Pyrazoles; Sulfonamides; Treatment Outcome	2013
Screening by telephone in the Alzheimer's disease anti-inflammatory prevention trial. Journal of Alzheimer's disease : JAD, 2013, Volume: 36, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Celecoxib; Cognition Disorders; Female; Geriatric Assessment; Humans; Male; Mass Screening; Naproxen; Neuropsychological Tests; Pyrazoles; Sulfonamides; Telephone	2013
Simulating effects of biomarker enrichment on Alzheimer's disease prevention trials: conceptual framework and example. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2014, Volume: 10, Issue:2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents; Biomarkers; Celecoxib; Computer Simulation; Cyclooxygenase 2 Inhibitors; Female; Humans; Longitudinal Studies; Male; Models, Statistical; Naproxen; Pyrazoles; Sulfonamides	2014
Follow-up evaluation of cognitive function in the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial and its Follow-up Study. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2015, Volume: 11, Issue:2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents; Celecoxib; Cognition; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Naproxen; Neuropsychological Tests; Nootropic Agents; Sensitivity and Specificity; Treatment Outcome	2015
Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline results. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2009, Volume: 5, Issue:2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Brain; Celecoxib; Cognition Disorders; Encephalitis; Female; Humans; Male; Naproxen; Neuropsychological Tests; Outcome Assessment, Health Care; Patient Selection; Placebos; Pyrazoles; Research Design; Sulfonamides; Time; Treatment Outcome	2009
Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT. PloS one, 2010, Feb-19, Volume: 5, Issue:2 Topics: 6-Ketoprostaglandin F1 alpha; Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Celecoxib; Drug Therapy, Combination; F2-Isoprostanes; Female; Humans; Male; Naproxen; Pyrazoles; Sulfonamides; Thromboxane B2; Treatment Outcome	2010
Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial. International journal of geriatric psychiatry, 2012, Volume: 27, Issue:4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cognition; Female; Humans; Longitudinal Studies; Male; Middle Aged; Naproxen; Pyrazoles; Sulfonamides	2012
Extended results of the Alzheimer's disease anti-inflammatory prevention trial. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2011, Volume: 7, Issue:4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Confidence Intervals; Double-Blind Method; Female; Humans; Longitudinal Studies; Male; Naproxen; Neuropsychological Tests; Peptide Fragments; Proportional Hazards Models; Psychiatric Status Rating Scales; Pyrazoles; Sulfonamides; tau Proteins	2011
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA, 2003, Jun-04, Volume: 289, Issue:21 Topics: Activities of Daily Living; Aged; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Progression; Double-Blind Method; Female; Humans; Isoenzymes; Lactones; Male; Membrane Proteins; Naproxen; Neuropsychological Tests; Proportional Hazards Models; Prostaglandin-Endoperoxide Synthases; Regression Analysis; Sulfones; Treatment Outcome	2003
Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology, 2007, May-22, Volume: 68, Issue:21 Topics: Adult; Aged; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Brain; Celecoxib; Cyclooxygenase Inhibitors; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Naproxen; Nootropic Agents; Patient Selection; Pyrazoles; Selection Bias; Sulfonamides; Treatment Failure; Treatment Outcome	2007
Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib. Archives of neurology, 2008, Volume: 65, Issue:7 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cognition; Cognition Disorders; Double-Blind Method; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Naproxen; Pyrazoles; Sulfonamides; Time Factors; Treatment Outcome	2008

Other Studies

23 other study(ies) available for naproxen and Acute Confusional Senile Dementia

Article	Year
The geminal dimethyl analogue of Flurbiprofen as a novel Abeta42 inhibitor and potential Alzheimer's disease modifying agent. Bioorganic & medicinal chemistry letters, 2006, Apr-15, Volume: 16, Issue:8 Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Cyclooxygenase Inhibitors; Disease Models, Animal; Flurbiprofen; Mice; Peptide Fragments	2006
Novel anilinophthalimide derivatives as potential probes for beta-amyloid plaque in the brain. Bioorganic & medicinal chemistry, 2010, Volume: 18, Issue:3 Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Brain; Humans; Mice; Phthalimides; Tomography, Emission-Computed, Single-Photon	2010
Reader response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease. Neurology, 2020, 03-31, Volume: 94, Issue:13 Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Asymptomatic Diseases; Humans; Naproxen	2020
Author response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease. Neurology, 2020, 03-31, Volume: 94, Issue:13 Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Asymptomatic Diseases; Humans; Naproxen	2020
Naproxen for presymptomatic Alzheimer disease: Is this the end, or shall we try again? Neurology, 2019, Apr-30, Volume: 92, Issue:18 Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Asymptomatic Diseases; Humans; Naproxen	2019
Can naproxen slow the progression of Alzheimer disease? Neurology, 2019, 04-30, Volume: 92, Issue:18 Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Asymptomatic Diseases; Disease Progression; Humans; Naproxen	2019
Effects of naproxen on immune responses in a colchicine-induced rat model of Alzheimer's disease. Neuroimmunomodulation, 2014, Volume: 21, Issue:6 Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Brain; Colchicine; Cytokines; Disease Models, Animal; Hydrocortisone; Lymphocytes; Male; Naproxen; Nitrites; Phagocytes; Plaque, Amyloid; Rats; Reactive Oxygen Species; Spleen; Time Factors; Tubulin Modulators	2014
Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease. International journal of molecular sciences, 2016, Jun-30, Volume: 17, Issue:7 Topics: Alzheimer Disease; Amyloid beta-Peptides; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cell Line; Cell Survival; Cyclooxygenase 2; Drug Stability; Flurbiprofen; Gene Expression; Humans; Interleukin-1beta; Naproxen; Peptide Fragments; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Thioctic Acid; Tumor Necrosis Factor-alpha	2016
Anti-inflammatory drugs fall short in Alzheimer's disease. Nature medicine, 2008, Volume: 14, Issue:9 Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cognition; Humans; Naproxen; Pyrazoles; Sulfonamides	2008
Can treatment with nonsteroidal anti-inflammatory drugs protect from dementia? Archives of neurology, 2009, Volume: 66, Issue:4 Topics: Adult; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Humans; Naproxen; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides; Treatment Outcome	2009
NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease. The Journal of clinical investigation, 2009, Volume: 119, Issue:12 Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Cell Cycle; Disease Models, Animal; Female; Humans; Ibuprofen; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microglia; Mutation; Naproxen; Neurons; Protein Processing, Post-Translational; Recombinant Proteins	2009
Naproxen interferes with the assembly of Aβ oligomers implicated in Alzheimer's disease. Biophysical journal, 2011, Apr-20, Volume: 100, Issue:8 Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Anti-Inflammatory Agents; Ligands; Molecular Dynamics Simulation; Molecular Sequence Data; Naproxen; Peptide Fragments; Protein Multimerization; Protein Stability; Protein Structure, Secondary; Solvents; Thermodynamics	2011
[F-18]FDDNP microPET imaging correlates with brain Aβ burden in a transgenic rat model of Alzheimer disease: effects of aging, in vivo blockade, and anti-Aβ antibody treatment. Neurobiology of disease, 2011, Volume: 43, Issue:3 Topics: Aging; Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloidosis; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Blocking; Binding, Competitive; Disease Models, Animal; Fluorine Radioisotopes; Humans; Naproxen; Nitriles; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Rats, Transgenic	2011
Molecular interactions of Alzheimer's biomarker FDDNP with Aβ peptide. Biophysical journal, 2012, Dec-05, Volume: 103, Issue:11 Topics: Alzheimer Disease; Amyloid beta-Peptides; Binding Sites; Biomarkers; Computer Simulation; Humans; Models, Chemical; Models, Molecular; Naproxen; Protein Binding; Protein Conformation	2012
NSAIDS for prevention? Protecting the brain while killing pain? Science (New York, N.Y.), 2002, Aug-23, Volume: 297, Issue:5585 Topics: Alzheimer Disease; Amyloid beta-Peptides; Anti-Inflammatory Agents, Non-Steroidal; Brain; Celecoxib; Cells, Cultured; Controlled Clinical Trials as Topic; Cyclooxygenase Inhibitors; Humans; Naproxen; Neurons; Peptide Fragments; Pyrazoles; Sulfonamides	2002
In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile. Neuroscience, 2003, Volume: 117, Issue:3 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Anti-Inflammatory Agents, Non-Steroidal; Autoradiography; Binding Sites; Binding, Competitive; Brain; Dose-Response Relationship, Drug; Female; Humans; Ibuprofen; In Vitro Techniques; Naproxen; Nitriles; Plaque, Amyloid; Radiopharmaceuticals; Tomography, Emission-Computed	2003
NSAIDs and hypertension. Archives of internal medicine, 2003, May-12, Volume: 163, Issue:9 Topics: Aged; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Double-Blind Method; Female; Humans; Lactones; Male; Middle Aged; Naproxen; Randomized Controlled Trials as Topic; Risk Factors; Sulfones	2003
Pass the tablet please. Alternative medicine review : a journal of clinical therapeutic, 2003, Volume: 8, Issue:3 Topics: Aged; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Ginkgo biloba; Humans; Lactones; Memory; Naproxen; Phytotherapy; Randomized Controlled Trials as Topic; Sulfones; Tablets	2003
Effect of NSAIDs on risk of Alzheimer's disease: confounding factors were not discussed. BMJ (Clinical research ed.), 2003, Sep-27, Volume: 327, Issue:7417 Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Humans; Lactones; Naproxen; Randomized Controlled Trials as Topic; Risk Factors; Sulfones	2003
Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. The Journal of biological chemistry, 2005, Feb-18, Volume: 280, Issue:7 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoates; Benzothiazoles; Biphenyl Compounds; Blood-Brain Barrier; Brain; Cell Line, Tumor; Congo Red; Curcumin; Diamines; Humans; Ibuprofen; Mice; Mice, Transgenic; Naproxen; Peptide Fragments; Plaque, Amyloid; Protein Binding; Protein Denaturation; Protein Structure, Quaternary; Pyridazines; Solubility; Thiazoles	2005
Multiple ligand binding sites on A beta(1-40) fibrils. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 2005, Volume: 12, Issue:1 Topics: Alzheimer Disease; Amyloid beta-Peptides; Benzothiazoles; Binding Sites; Congo Red; Fluorescent Dyes; Humans; Ibuprofen; Ligands; Models, Chemical; Molecular Structure; Naproxen; Peptide Fragments; Protein Binding; Thiazoles	2005
Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals. Journal of neurochemistry, 2001, Volume: 76, Issue:6 Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Benzoates; Cell Death; Cell Line; Cell Nucleus; Cell Survival; Dexamethasone; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Free Radicals; Humans; Hydrocortisone; Imidazoles; Indomethacin; Inflammation; Mefenamic Acid; Naproxen; Neuroblastoma; Neurons; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Rats; Tumor Cells, Cultured	2001
Nonsteroidal drugs and Alzheimer's disease. The New England journal of medicine, 2002, Apr-11, Volume: 346, Issue:15 Topics: Alzheimer Disease; Amyloid beta-Peptides; Anti-Inflammatory Agents, Non-Steroidal; Humans; Ibuprofen; Naproxen	2002